Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

130.97 -4.07 (-3.02%)
Streaming Delayed Price Updated: 1:04 PM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Courts Reinstate Ban On Apple Watches With Blood Oxygen Sensors ↗
A federal appeals court on Wednesday shut down Apple's attempt to allow U.S. imports of Apple Watches with blood-oxygen sensors while it appeals a ban on the products. 
Via Benzinga
News headline image
Apple Dodges Import Ban In Apple Watch Patent Battle With Masimo ↗
Apple potentially avoids import ban for Apple Watch models in patent dispute with Masimo, with software redesign to remove blood-oxygen feature. 
Via Benzinga
Topics Intellectual Property
News headline image
ITC Wants Apple Ban Reinstated, Calls Apple's Arguments 'Weak And Unconvincing' ↗
The U.S. International Trade Commission (ITC) has opposed Apple's plea to put on hold an import ban on certain Apple Watch models. 
Via Benzinga
News headline image
Apple's Win ↗
We've also got some productivity tips for the new year. 
Via The Motley Fool
News headline image
Apple Stock Is Still A Buy. Here’s Why. ↗
Investors should remain bullish on AAPL stock as the company grows its services business and brings new products to market. 
Via InvestorPlace
News headline image
There's Uncertainty Around Apple's Patent Appeal For Watch, Masimo's Royalty Exposure Is Priced In - Analyst Downgrades ↗
Needham downgraded Masimo Corporation (NASDAQ: MASI), noting that though Apple Inc (NASDAQ: AAPL) royalties are not certain, but are mostly priced into MASI shares. 
Via Benzinga
Topics Intellectual Property
News headline image
Recap: Masimo Q3 Earnings ↗
 
Via Benzinga
News headline image
Bear Of The Day: Masimo ↗
Masimo (MASI) , a medical device company, has seen significant downward pressure on its earnings estimates over the last two months, downgrading the stock to a Zacks Rank #5 (Strong Sell), and... 
Via Talk Markets
News headline image
Benzinga Bulls And Bears: Tesla, Apple, Microsoft, Plug Power And Analyst Sees Precursor To Dogecoin Rally ↗
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
News headline image
Apple Is 'Working Desperately' To Overcome Watch Import Ban With Software Redesign, Aiming For January Launch Amid Patent-Infringement Case: Report ↗
Apple is redesigning software for compliance, hoping to gain approval from a U.S. customs agency by Jan.12 to sell compliant device versions. 
Via Benzinga
News headline image
Joe Biden Vs. Apple Watch: White House Upholds Ban, Masimo CEO One Of President's 'Closest Friends' ↗
The Apple Watch vs. Masimo battle could spill over into politics with the CEO of Masimo a major Democratic donor and friend of Joe Biden. 
Via Benzinga
News headline image
S&P 500 Inches Higher, Small-Cap Rally Stalls, Bitcoin Sinks: What's Driving Markets Thursday? ↗
Wall Street is navigating another quiet session characterized by low trading volumes in the post-holiday period. The S&P 500 index continues its gradual ascent toward retesting its all-time highs,... 
Via Benzinga
Topics Stocks
News headline image
Apple’s Market Maneuvers: Is AAPL Stock a Smart Buy at $193? ↗
A ban on the Apple Watch could hit AAPL stock hard as the wearable is the tech stock's second biggest money-maker 
Via InvestorPlace
News headline image
How A Late-Night Email To Tim Cook 10 Years Ago Possibly Triggered Masimo's Battle To Get Apple Watch Banned ↗
In 2013, a scientist named Marcelo Lamego fired off an email to Cook, pitching a vision that could propel Apple to the forefront of the medical, fitness, and wellness market, Bloomberg reported. 
Via Benzinga
News headline image
US Stocks Pause, Gold Rises As Dollar, Treasury Yields Fall: What's Driving Markets Wednesday? ↗
The U.S. stock market experienced a quiet day on Wednesday, with major indices showing minimal movement amid typical year-end low volume activity. The S&P 500 hovered around 4,777 points, remaining... 
Via Benzinga
News headline image
Apple Wins Temporary Reprieve in Watch Import Ban Over Masimo's Pulse Oximetry Patent Row ↗
On Wednesday, a U.S. 
Via Benzinga
Topics Intellectual Property
News headline image
Apple Pauses Watch Sale Due to Technology Dispute. What Should You Do With the Stock? ↗
Apple must halt its Apple Watch sales before Dec. 25. 
Via The Motley Fool
News headline image
Apple Appeals Against Smartwatch Sales Ban After White House Declines To Interfere ↗
Apple appeals against a smartwatch sales ban, filing for court review after the White House declines involvement in the U.S. International Trade Commission's imposed restriction due to a patent dispute... 
Via Benzinga
Topics Intellectual Property
News headline image
Apple's $17B Smartwatch Business At Risk, Cutting-Edge AI Tech 'HUGS' And More: This Week In Appleverse ↗
From threats to its smartwatch operations to a significant increase in its card savings interest rate, let's delve into the Apple-centric news that unfolded this past week. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Dow Jones Giants Apple, Microsoft Lead Five Stocks Near Buy Points ↗
Investors should keep tabs on these five stocks trading tightly. 
Via Investor's Business Daily
Topics Stocks
News headline image
'They Haven't Called:' Masimo CEO Awaits Apple's Move In Watch Patent Infringement Dispute ↗
Masimo CEO Joe Kiani has expressed willingness to settle the ongoing patent dispute with Apple related to the Apple Watch Ultra 2 and Apple Watch Series 9, saying that the tech giant has not initiated... 
Via Benzinga
Topics Intellectual Property
News headline image
Biden Administration 'Tracking' Apple Watch Case — Could White House Veto The Ban? ↗
The Biden administration is closely monitoring a potential ban on Apple Watch sales in the U.S. due to a patent dispute with Masimo Corp, with the U.S. Trade Representative considering whether to lift... 
Via Benzinga
Topics Intellectual Property
News headline image
Apple Scrambles To Save $17B Smartwatch Business From Impending Ban: Report ↗
Apple is reportedly working to salvage its $17 billion smartwatch business from an impending U.S. ban, set to take effect on Dec. 25, by tweaking algorithms related to blood oxygen level measurement,... 
Via Benzinga
Topics Intellectual Property
News headline image
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF? ↗
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,... 
Via Benzinga
Topics ETFs
News headline image
Wells Fargo Maintains Equal-Weight Rating for Masimo: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Robinhood, eBay, Upstart And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Big Tech Earnings, Results From a Couple of Financial Companies, and a Look at Spotify ↗
We also chat with author Michael Lewis about Sam Bankman-Fried. 
Via The Motley Fool
News headline image
Masimo Might See Potential Royalty Windfall From ITC's Exclusion Order On Apple Watch: Analyst ↗
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI)  
Via Benzinga
News headline image
Masimo Surges After Winning A Potential $100 Million Battle Against Apple ↗
Federal officials say Apple violated patent laws in its Apple Watch. 
Via Investor's Business Daily
Topics Intellectual Property
News headline image
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.